Over the last 2 decades, significant progress has been made in our understanding of the genomics, tumor immune microenvironment, and immunogenicity of malignant melanoma. Historically, the prognosis ...

Journal of Nuclear Medicine November 2024, jnumed.124.268751; DOI: https://doi.org/10.2967/jnumed.124.268751 ...

Journal of Nuclear Medicine November 2024, jnumed.124.268119; DOI: https://doi.org/10.2967/jnumed.124.268119 ...

PET-Based TheraP Eligibility and Outcomes of VISION-Eligible Patients with Metastatic Castration-Resistant Prostate Cancer Who Received 177 Lu-PSMA-617: Importance of 18 F-FDG–Avid Discordant Findings ...

Journal of Nuclear Medicine November 2024, jnumed.124.267963; DOI: https://doi.org/10.2967/jnumed.124.267963 The integration of PET/CT systems, which was initially ...

Journal of Nuclear Medicine November 2024, jnumed.124.268807; DOI: https://doi.org/10.2967/jnumed.124.268807 ...

Journal of Nuclear Medicine November 2024, jnumed.124.268167; DOI: https://doi.org/10.2967/jnumed.124.268167 ...

Journal of Nuclear Medicine November 2024, jnumed.124.268509; DOI: https://doi.org/10.2967/jnumed.124.268509 ...

Journal of Nuclear Medicine October 2024, jnumed.124.268277; DOI: https://doi.org/10.2967/jnumed.124.268277 ...

Journal of Nuclear Medicine November 2024, jnumed.124.268451; DOI: https://doi.org/10.2967/jnumed.124.268451 ...

Journal of Nuclear Medicine October 2024, jnumed.124.268796; DOI: https://doi.org/10.2967/jnumed.124.268796 You do not have access to the full text of this article ...